Abstract:BACKGROUND Citrate solution has been suggested as an effective and safe catheter lock in hemodialysis. However, whether a citrate lock is superior to a heparin lock in preventing catheter-related infections and maintaining catheter patency is inconclusive. STUDY DESIGN A systematic review and meta-analysis was performed by searching in PubMed, EMBASE, Ovid, the Cochrane Library, and Web of Science databases and major nephrology journals. SETTING & POPULATION Patients receiving hemodialysis with central venous catheters. SELECTION CRITERIA FOR STUDIES Randomized controlled trials comparing citrate locks with heparin locks in hemodialysis patients with central venous catheters. INTERVENTION Locking central venous catheters with citrate locks. OUTCOMES Primary outcomes include catheter-related bloodstream infection (CRBSI), exit-site infection, catheter removal for poor flow, and thrombolytic treatment. RESULTS 13 randomized controlled trials (1,770 patients, 221,064 catheter-days) met the inclusion criteria. Pooled analyses found that citrate locks could significantly reduce the incidence of CRBSI (risk ratio [RR], 0.39; 95% CI, 0.27-0.56; P < 0.001). Subgroup analysis showed that antimicrobial-containing citrate locks (citrate + gentamicin, citrate + taurolidine, and citrate + methylene blue + methylparaben + propylparaben) were superior to heparin locks in the prevention of CRBSI (P < 0.001, P = 0.003, and P = 0.008, respectively), whereas citrate alone failed to show a similar advantage (P = 0.2). Low- (1.04%-4%) to moderate-concentration (4.6%-7%) citrate locks were associated with decreased CRBSI incidence (P < 0.001 and P = 0.003, respectively), but patients receiving high-concentration (30%-46.7%) citrate and heparin locks had similar incidences (P = 0.3). The incidence of bleeding episodes (RR, 0.48; 95% CI, 0.30-0.76; P = 0.002) was significantly lower in patients receiving citrate locks, whereas both groups were similar in terms of exit-site infection (P = 0.2), catheter removal for poor flow (P = 0.9), thrombolytic treatment (P = 0.8), all-cause death (P = 0.3), catheter thrombosis (P = 0.9), mean catheter duration (P = 0.2), CRBSI-free catheter survival (P = 0.2), and catheter-related readmission (P = 0.5). LIMITATIONS All studies used in the meta-analysis were performed in Western countries. The applicability of our findings to other regions remains to be clarified. CONCLUSIONS An antimicrobial-containing citrate lock is better than a heparin lock in the prevention of catheter-related infection, while citrate alone fails to show a similar advantage. Citrate locks of low to moderate concentrations, rather than high concentration, were superior to heparin locks in preventing CRBSI. Citrate locks also might decrease bleeding episodes. No difference has been identified in the efficacy to prevent exit-site infection or preserve catheter patency between citrate and heparin locks.

Citrate Versus Heparin Lock for Hemodialysis Catheters: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Citrate Versus Heparin Lock for Prevention of Hemodialysis Catheter-Related Complications: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Anticoagulant Therapies Versus Heparin for the Prevention of Hemodialysis Catheter-Related Complications: Systematic Review and Meta-Analysis of Prospective Randomized Controlled Trials.

Comparative Efficacy and Safety of Lock Solutions for the Prevention of Catheter-Related Complications Including Infectious and Bleeding Events in Adult Haemodialysis Patients: a Systematic Review and Network Meta-Analysis

Comparative Efficacy and Safety of Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Network Meta-Analysis

Successful Prevention of Cuffed Hemodialysis Catheter-Related Infection Using an Antibiotic Lock Technique by Strictly Catheter-Restricted Antibiotic Lock Solution Method.

Low-dose Versus High-Dose Heparin Locks for Hemodialysis Catheters: a Systematic Review and Meta-Analysis

Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis.

The CLOCK trial, a double-blinded randomized controlled trial: Trisodium citrate 30% and minocycline 3 mg/mL plus EDTA 30 mg/mL are effective and safe for catheter patency maintenance among CKD 5D patients on hemodialysis

The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients

Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial

Efficacy of Urokinase in Maintaining Patency of Hemodialysis Catheters: A Meta-Analysis

Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis

A Randomized Controlled Trial on the Heparin Lock Concentration of Hemodialysis Intra-Jugular Vein Dual Lumen Catheter

Taurolock versus saline 5% on preventing infection and dysfunction of hemodialysis catheters; a randomized, double blind controlled clinical trial

Meta analysis on feasibility of sealing central venous catheter using pure heparin in hemodialysis patients

Application of 70 ％ ethanol lock for tunnel cuffed catheter in maintenance hemodialysis patients

Effectiveness of Silver-Impregnated Central Venous Catheters for Preventing Catheter-Related Blood Stream Infections: a Meta-Analysis.

Locking solutions for prevention of central venous access device complications in the adult critical care population: A systematic review

Antimicrobial Lock Solutions for the Prevention of Catheter-Related Infection in Patients Undergoing Haemodialysis: Study Protocol for Network Meta-Analysis of Randomised Controlled Trials

Citrate Versus Unfractionated Heparin for Anticoagulation in Continuous Renal Replacement Therapy.